Michael Branson1, John Whitehead
1Novartis Pharma AG, Lichtstrasse 35, CH-4056, Basel, Switzerland. michael.branson@pharma.novartis.com
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
A new score test accounts for patient non-compliance in binary clinical trials without losing statistical power compared to the intention-to-treat principle. This method provides accurate sample size calculations for trial design.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: